---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-154309"
form_type: "8-K"
ticker: "CABA"
cik: "0001759138"
company_name: "Cabaletta Bio, Inc."
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:34:52.807859+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Cabaletta Bio 2024 annual meeting: Bollard and Henriques elected as directors, EY ratified

## Summary
- Stockholders elected Catherine Bollard and Richard Henriques as Class II directors; Bollard received 26,225,488 for, 12,001,379 withheld; Henriques received 37,806,806 for, 433,474 withheld.
- Ratification of Ernst & Young LLP as independent auditor for FY2024 passed with 41,355,429 for, 38,098 against, 5,728 abstain.
- 46,804,820 shares were outstanding as of the April 4, 2024 record date; no other matters voted on.

## SEC filing metadata
- accession: 0001193125-24-154309
- form_type: 8-K
- ticker: CABA
- cik: 0001759138
- company_name: Cabaletta Bio, Inc.
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759138/000119312524154309/0001193125-24-154309-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759138/000119312524154309/d829742d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-154309
- JSON: https://secwatch.observer/filing/0001193125-24-154309.json
- Plain text: https://secwatch.observer/filing/0001193125-24-154309.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.